Ronald Blue Trust, Inc. Cardlytics, Inc. Transaction History
Ronald Blue Trust, Inc.
- $7.98 Billion
- Q3 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Cardlytics, Inc. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 833 shares of CDLX stock, worth $3,223. This represents 0.0% of its overall portfolio holdings.
Number of Shares
833
Previous 384
116.93%
Holding current value
$3,223
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CDLX
# of Institutions
130Shares Held
31MCall Options Held
1.23MPut Options Held
775K-
Cliff Sosin Cas Investment Partners, LLC | New York, Ny6.42MShares$24.8 Million1.36% of portfolio
-
Black Rock Inc. New York, NY3.15MShares$12.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$10.3 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY2.23MShares$8.61 Million0.65% of portfolio
-
Kps Global Asset Management Uk LTD London, X01.22MShares$4.72 Million0.93% of portfolio
About Cardlytics, Inc.
- Ticker CDLX
- Exchange NASDAQ
- Sector Communication Services
- Industry Advertising Agencies
- Shares Outstandng 32,893,800
- Market Cap $127M
- Description
- Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and var...